Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Learn the scenarios where index funds tend to outperform actively managed funds and the factors that drive these outcomes.
15,347 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Evernorth moves to go public through a SPAC merger, aiming to convert XRP exposure into a participatory, yield-genera...
When markets turn sour, some energy stocks stand out for safety and reliability. This guide highlights two midstream ...
Investors are asking if american express stock still makes sense after the latest earnings. This article breaks down ...
A government-backed move accelerates commercialization of quantum tech, and three ETFs are steering investors through...
Circle launches cirBTC on Ethereum, signaling a bet that wrapped Bitcoin can serve as bank-grade collateral for insti...
In a bold move amid a choppy market, a retiree turned down $100,000 in upfront dividend income to pursue a growth str...
A nobel laureate economist warns that anxiety about AI displacing workers risks shaping real outcomes, not just headl...
A tiny, disciplined bet on a Robinhood Chain meme coin led to a dramatic payoff in weeks. This piece unpacks what hap...
The Ethereum Foundation has begun staking a portion of its treasury, deploying 2,016 ETH as part of a broader move in...
A major fundraise for the Zcash Open Development Lab is fueling rapid progress for privacy technology. This piece exp...
When a high-profile TV season is shelved, the ripple effects go beyond the screen. This article breaks down the finan...